Efficient Epidermal Growth Factor Receptor Targeting Oligonucleotide as a Potential Molecule for Targeted Cancer Therapy

Epidermal growth factor receptor (EGFR) is associated with the progression of a wide range of cancers including breast, glioma, lung, and liver cancer. The observation that EGFR inhibition can limit the growth of EGFR positive cancers has led to the development of various EGFR inhibitors including m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Philippovich, Svetlana, Mao, Jun, Veedu, Rakesh N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801465/
https://www.ncbi.nlm.nih.gov/pubmed/31546749
http://dx.doi.org/10.3390/ijms20194700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801465/
https://www.ncbi.nlm.nih.gov/pubmed/31546749
http://dx.doi.org/10.3390/ijms20194700

Ejemplares similares